logo
  • genedrive.com
  • About us
    • Company profile
    • Board of directors
    • Advisors
  • Our product
  • Press releases
  • Careers
    • Careers
    • Applicants Privacy Notice
  • Investor relations
    • AIM Rule 26
    • Investor relations
    • Shareholders
    • Share price information
    • Regulatory news
    • Reports & presentations
    • Analyst notes
    • Constitutional documents
    • Investor news
    • Corporate governance
    • Investor contacts
    • Company information

Shareholders

Home > Investor relations > Shareholders

Identity and percentage holding of significant shareholders
 

Substantial holdings Shares held %
     
Directors and related shareholders  
Ian Gilham 614,295 0.66%
David Budd 293,710 0.32%
Tom Lindsay 262,717 0.28%
Chris Yates 67,554 0.07%
Total Directors' holdings 1,238,276 1.34%
     
Total shares in issue 92,549,946 100.00%

 

Shareholder information

genedrive shares are quoted and traded on the AIM market of the London Stock Exchange.

Authorised Share Capital: No authorised maximum number of shares are required. There are no shares held in treasury and there are no restrictions on transfer.

Issued Share Capital: The total number of genedrive plc ordinary shares of 1.5p each in issue is 92,542,446.

Number of AIM securities not in public hands is 1,238,276 or 1.34%.

Text updated:  31/03/2023

Latest reports

share price graph

31 March 2023

Interim Report and accounts 31 December 2022

View all reports >

Investor News

Wednesday February 03, 2021

Genedrive close to hitting the market with coronavirus tests

Friday May 19, 2023

Genedrive jumps 24% after UK regulatory thumbs up

Thursday March 30, 2023

Genedrive receives final approval from NICE for MT-RNR1 ID kit

View all news >

  • Privacy
  • Terms of use
  • Site map

© 2017-23 genedrive plc

genedrive plcThis site uses cookies for tracking and statistical purposes. Please read our privacy policy for more information.

Don't show this againclose